MCL1 and hydrops fetalis: Afatinib treatment reduced MCL‐1 protein levels (Fig. S11D), while Mcl‐1 mRNA levels in HF epidermal cells (Lin–/CD49f +/Sca‐1–) were unaffected (Fig. S11E).